Travere Therapeutics, Inc.
Industry: Life Sciences ・ $TVTX on Nasdaq
Insider Sale
+$4,888
-0.73%
Shares
Shares Volume: 514 Shares
Average Share Price: $9.51
INSIDER
Cline Christopher R.
CHIEF FINANCIAL OFFICER (Officer)
reported on Sep 5 2024
traded on Sep 4 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 70,335 |
| PURCHASES/SALES 1Y | 0 / 4 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $11,389.09 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 1 |
| PURCHASES/SALES 1Y | 0 / 16 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $32,904.02 |
| COMPANY PREVIOUS TRADES |